A recent study indicates that patients who stop using new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end traditional diet and exercise plans.
Findings released in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing such treatments must be cognizant of the potential of rapid weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment mass within about one and a half years.
Comparing Treatments
The analysis, which reviewed dozens of trials involving over 9,000 of patients, contrasted the outcomes of these new drugs with other pills.
The team note that people who lose weight through lifestyle changes alone generally have a less rapid weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Quick Rebound
Experts propose the way of the jabs explains the accelerated weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Issue?
The NHS advise the injections for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, considering the likelihood of weight regain, the therapy might need to be ongoing.
This perspective is supported by drug manufacturers, who say that the results "highlight the chronic character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
People who have discontinued the medication explain a powerful return of hunger.
"I experienced something activating and you're instantly extremely hungry," described an individual.
This difficulty is compounded if individuals have not adopted lasting lifestyle or habit changes during treatment.
Significant Adoption
Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is more common among women than males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
Ultimately, experts emphasize that while these medications are powerful agents for weight loss, they are not a permanent fix and lasting health benefits hinges on combined lifestyle management.
